Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation by V. A. Ionin, E. I. Barashkova, A. M. Ananev, V. A. Pavlova, E. L. Zaslavskaya, E. I. Baranova

Get full text

Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation by V. A. Ionin, E. L. Zaslavskaya, E. I. Barashkova, V. A. Pavlova, A. M. Ananev, A. N. Morozov, E. I. Baranova

Get full text

What is the role of profibrogenic and proinflammatory factors in developing atrial fibrillation associated with metabolic syndrome components? by V. A. Ionin, E. I. Barashkova, V. A. Pavlova, G. I. Borisov, K. A. Averchenko, E. L. Zaslavskaya, E. I. Baranova

Get full text

Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice? by V. A. Ionin, E L Zaslavskaya, E I Barashkova, V A Pavlova, G I Borisov, K A Averchenko, A N Morozov, E I Baranova, E V Schlyachto

Get full text